Clinical validation of full genotyping CLART® HPV4S assay on SurePath and ThinPrep collected screening samples according to the international guidelines for human papillomavirus test requirements for cervical screening

BACKGROUND: To ensure the highest quality of human papillomavirus (HPV) testing in primary cervical cancer screening, novel HPV assays must be evaluated in accordance with the international guidelines. Furthermore, HPV assay with genotyping capabilities are becoming increasingly important in triage...

Descripción completa

Detalles Bibliográficos
Autores principales: Ejegod, Ditte Møller, Lagheden, Camilla, Bhatia, Ramya, Pedersen, Helle, Boada, Elia Alcañiz, Sundström, Karin, Cortés, Javier, Josë, F. Xavier Bosch, Cuschieri, Kate, Dillner, Joakim, Bonde, Jesper
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7203972/
https://www.ncbi.nlm.nih.gov/pubmed/32375689
http://dx.doi.org/10.1186/s12885-020-06888-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7203972/
https://www.ncbi.nlm.nih.gov/pubmed/32375689
http://dx.doi.org/10.1186/s12885-020-06888-0

Ejemplares similares